Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Pembrolizumab/Lenvatinib With and Without Healthy Donor FMT (hdFMT) in Relapsed/ Refractory (R/R) Melanoma

Diwakar Davar · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
pd-1 refractory advanced melanoma, cd8+ t-cells, cd8+ effector t cells, foxp3+ regulatory t-cells (t-regs), hdfmt (healthy donor fecal-microbiota transplant), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 918572
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.